Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review

Overview of attention for article published in Breast Cancer Research and Treatment, February 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 1 X user
patent: 3 patents

wikipedia: 3 Wikipedia pages

Citations

dimensions_citation: 317 Dimensions

Readers on

mendeley: 404 Mendeley

Summary X Patents Wikipedia Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

INHIBITION OF FKBP1A FOR THE TREATMENT OF TRIPLE-NEGATIVE MAMMARY CARCINOMA

Application WO-2021180840-A1

World Intellectual Property Organisation (WIPO)

COMBINATION THERAPY FOR PI3K-ASSOCIATED DISEASE OR DISORDER

Application US-20210236501-A1

United States of America

IMPROVED METHODS FOR THE EARLY DIAGNOSIS OF UTERINE LEIOMYOMAS AND LEIOMYOSARCOMAS

Application WO-2020212580-A1

World Intellectual Property Organisation (WIPO)